Call us today on +44 (0)7757 948 052
Specialist pharmaceutical development consultancy for paediatric medicines

What we do

Jenny Walsh Consulting Ltd is based in BioCity Nottingham, UK and offers specialist pharmaceutical consultancy support, with a particular focus on paediatric product development, from early phase prototypes to products for marketing.

Regulations in both Europe and the USA mandate the development of paediatric medicines for new products and incentives are in place for the development of off-patent (generic) paediatric products. The formulation of medicines for children can be particularly challenging due to the diverse patient population and the need to consider patient acceptability and the safety of both excipients and the API.

We work closely with clients in a flexible manner to assist them with their paediatric formulation programmes, to enable them to meet their business needs, patient requirements and regulatory obligations, as efficiently as possible.

Our services include

Why choose Jenny Walsh Consulting Ltd

  • Extensive experience and recognised expertise in paediatric product development
  • Facilitates efficiencies and best practice
  • Enables compliance with regulatory requirements
  • Expedites the development of products that meet paediatric patient needs

Company Director Jenny Walsh is a PhD pharmacist with over 20 years experience in the pharmaceutical and consumer healthcare industries (Glaxo SmithKline, Napp Research Centre, The Boots Company, Reckitt Benckiser, AstraZeneca) where she has held a variety of roles within Pharmaceutical Development and Medical Affairs.

Jenny has recognised expertise in paediatric product development; she has been responsible for the design and implementation of a paediatric medicine development process for a global pharmaceutical company and successfully worked on numerous paediatric development projects and PIPs. She is also an associate member of the European Paediatric Formulation Initiative and has presented at conferences and authored publications.

Membership of Professional Organisations

  • The Royal Pharmaceutical Society of Great Britain
  • General Pharmaceutical Council
  • The UK Academy of Pharmaceutical Scientists
  • The American Association of Pharmaceutical Scientists
  • European Paediatric Formulation Initiative
  • Neonatal and Paediatric Pharmacists Group

Recent Publications 

  • European Paediatric Formulation Initiative (EuPFI) - Formulating ideas for better medicines for children. AAPS PharmSciTech (2016) DOI: 10.1208/s12249-016-0584-1
  • Reflection on the pharmaceutical formulation challenges associated with a Paediatric Investigation Plan for an off-patent drug. AAPS PharmSciTech (2016) DOI: 10.11208/s12249-016-0527-x
  • Devices for oral and respiratory medicines: What do healthcare professionals think? Int. J. Pharm. (2015) 492: 304-315.
  • Playing hide and seek with poorly tasting paediatric medicines: do not forget the excipients. Adv. Drug Del. Rev. (2014) 73: 14-33.
  • Challenges and recent developments in administration devices for paediatrics. BioPharma Asia (2014) 3 (6).
  • Formulating better medicines for children: 4th EuPFI Conference. Therapeutic Delivery (2013) 4: 21-25.
  • A benefit/risk approach towards selecting appropriate pharmaceutical dosage forms - An application for paediatric dosage form selection. Int. J. Pharm. (2012) 435: 115-123.
  • Excipients for the formulation of medicines for children European Industrial Pharmacy (2012) Issue 13: 14-16.
  • Delivery Devices for the Administration of Paediatric Formulations: Overview of Current Practice, Challenges and Recent Developments. Int. J. Pharm. (2011) 415: 221-231.
Connect With Us Join us on LinkedIn

Address BioCity Nottingham
Pennyfoot Street
Nottingham
NG1 1GF

Telephone Number +44 (0)7757 948 052

Email Address info@jennywalshconsulting.com

Company Reg No: 07753637